These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 37289024

  • 1. Unraveling the Link between Class 1A PI3-Kinase, Autophagy, and Myelodysplasia.
    Ames K, Gritsman K.
    Autophagy; 2024 Apr; 20(4):952-954. PubMed ID: 37289024
    [Abstract] [Full Text] [Related]

  • 2. PI3-kinase deletion promotes myelodysplasia by dysregulating autophagy in hematopoietic stem cells.
    Ames K, Kaur I, Shi Y, Tong MM, Sinclair T, Hemmati S, Glushakow-Smith SG, Tein E, Gurska L, Steidl U, Dubin R, Shan J, Montagna C, Pradhan K, Verma A, Gritsman K.
    Sci Adv; 2023 Feb 22; 9(8):eade8222. PubMed ID: 36812307
    [Abstract] [Full Text] [Related]

  • 3. Quercetin induces autophagy in myelodysplastic bone marrow including hematopoietic stem/progenitor compartment.
    Daw S, Law S.
    Environ Toxicol; 2021 Feb 22; 36(2):149-167. PubMed ID: 32902906
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. PI3 kinase alpha and delta promote hematopoietic stem cell activation.
    Hemmati S, Sinclair T, Tong M, Bartholdy B, Okabe RO, Ames K, Ostrodka L, Haque T, Kaur I, Mills TS, Agarwal A, Pietras EM, Zhao JJ, Roberts TM, Gritsman K.
    JCI Insight; 2019 May 23; 5(13):. PubMed ID: 31120863
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Loss of Function of DOCK4 in Myelodysplastic Syndromes Stem Cells is Restored by Inhibitors of DOCK4 Signaling Networks.
    Sundaravel S, Kuo WL, Jeong JJ, Choudhary GS, Gordon-Mitchell S, Liu H, Bhagat TD, McGraw KL, Gurbuxani S, List AF, Verma A, Wickrema A.
    Clin Cancer Res; 2019 Sep 15; 25(18):5638-5649. PubMed ID: 31308061
    [Abstract] [Full Text] [Related]

  • 9. Setd2 deficiency impairs hematopoietic stem cell self-renewal and causes malignant transformation.
    Zhang YL, Sun JW, Xie YY, Zhou Y, Liu P, Song JC, Xu CH, Wang L, Liu D, Xu AN, Chen Z, Chen SJ, Sun XJ, Huang QH.
    Cell Res; 2018 Apr 15; 28(4):476-490. PubMed ID: 29531312
    [Abstract] [Full Text] [Related]

  • 10. Involvement and functional impairment of the CD34(+)CD38(-)Thy-1(+) hematopoietic stem cell pool in myelodysplastic syndromes with trisomy 8.
    Nilsson L, Astrand-Grundström I, Anderson K, Arvidsson I, Hokland P, Bryder D, Kjeldsen L, Johansson B, Hellström-Lindberg E, Hast R, Jacobsen SE.
    Blood; 2002 Jul 01; 100(1):259-67. PubMed ID: 12070035
    [Abstract] [Full Text] [Related]

  • 11. SF3B1-initiating mutations in MDS-RSs target lymphomyeloid hematopoietic stem cells.
    Mortera-Blanco T, Dimitriou M, Woll PS, Karimi M, Elvarsdottir E, Conte S, Tobiasson M, Jansson M, Douagi I, Moarii M, Saft L, Papaemmanuil E, Jacobsen SEW, Hellström-Lindberg E.
    Blood; 2017 Aug 17; 130(7):881-890. PubMed ID: 28634182
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Immunophenotypic aberrant hematopoietic stem cells in myelodysplastic syndromes: a biomarker for leukemic progression.
    van Spronsen MF, Hanekamp D, Westers TM, van Gils N, Vermue E, Rutten A, Jansen JH, Lissenberg-Witte BI, Smit L, Schuurhuis GJ, van de Loosdrecht AA.
    Leukemia; 2023 Mar 17; 37(3):680-690. PubMed ID: 36792658
    [Abstract] [Full Text] [Related]

  • 14. Autophagy preserves hematopoietic stem cells by restraining MTORC1-mediated cellular anabolism.
    Borsa M, Obba S, Richter FC, Zhang H, Riffelmacher T, Carrelha J, Alsaleh G, Jacobsen SEW, Simon AK.
    Autophagy; 2024 Jan 17; 20(1):45-57. PubMed ID: 37614038
    [Abstract] [Full Text] [Related]

  • 15. Coexistence of aberrant hematopoietic and stromal elements in myelodysplastic syndromes.
    Abbas S, Kini A, Srivastava VM, M MT, Nair SC, Abraham A, Mathews V, George B, Kumar S, Venkatraman A, Srivastava A.
    Blood Cells Mol Dis; 2017 Jul 17; 66():37-46. PubMed ID: 28822917
    [Abstract] [Full Text] [Related]

  • 16. Deficiency and haploinsufficiency of histone macroH2A1.1 in mice recapitulate hematopoietic defects of human myelodysplastic syndrome.
    Bereshchenko O, Lo Re O, Nikulenkov F, Flamini S, Kotaskova J, Mazza T, Le Pannérer MM, Buschbeck M, Giallongo C, Palumbo G, Li Volti G, Pazienza V, Cervinek L, Riccardi C, Krejci L, Pospisilova S, Stewart AF, Vinciguerra M.
    Clin Epigenetics; 2019 Aug 22; 11(1):121. PubMed ID: 31439048
    [Abstract] [Full Text] [Related]

  • 17. SPAG6 silencing induces apoptosis in the myelodysplastic syndrome cell line SKM‑1 via the PTEN/PI3K/AKT signaling pathway in vitro and in vivo.
    Yin J, Li X, Zhang Z, Luo X, Wang L, Liu L.
    Int J Oncol; 2018 Jul 22; 53(1):297-306. PubMed ID: 29749435
    [Abstract] [Full Text] [Related]

  • 18. Deletion of Asxl1 results in myelodysplasia and severe developmental defects in vivo.
    Abdel-Wahab O, Gao J, Adli M, Dey A, Trimarchi T, Chung YR, Kuscu C, Hricik T, Ndiaye-Lobry D, Lafave LM, Koche R, Shih AH, Guryanova OA, Kim E, Li S, Pandey S, Shin JY, Telis L, Liu J, Bhatt PK, Monette S, Zhao X, Mason CE, Park CY, Bernstein BE, Aifantis I, Levine RL.
    J Exp Med; 2013 Nov 18; 210(12):2641-59. PubMed ID: 24218140
    [Abstract] [Full Text] [Related]

  • 19. Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes.
    Falconi G, Fabiani E, Fianchi L, Criscuolo M, Raffaelli CS, Bellesi S, Hohaus S, Voso MT, D'Alò F, Leone G.
    Exp Hematol; 2016 Jan 18; 44(1):75-83.e1-4. PubMed ID: 26521017
    [Abstract] [Full Text] [Related]

  • 20. Selective Autophagy in Normal and Malignant Hematopoiesis.
    Koschade SE, Brandts CH.
    J Mol Biol; 2020 Jan 03; 432(1):261-282. PubMed ID: 31260695
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.